Saar Gill, MD: Combining CAR T-Cell Therapy With Ibrutinib in CLL Patients

1 Views
administrator
administrator
07/14/23

Adding ibrutinib to treatment with CAR T-cell therapy was feasible, led to deeper remissions, and reduced the severity of cytokine release syndrome in patients with chronic lymphocytic leukemia.

Show more

0 Comments Sort By

No comments found

Facebook Comments

Up next